• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内脂素水平与妊娠期糖尿病:系统评价和荟萃分析。

Visfatin level and gestational diabetes mellitus: a systematic review and meta-analysis.

机构信息

Department of Anesthesiology, Ningbo No.6 Hospital, Ningbo, China.

Department of Cardiovascular Medicine, Southern Medical University Affiliated Fengxian Hospital, Shanghai, China.

出版信息

Arch Physiol Biochem. 2021 Oct;127(5):468-478. doi: 10.1080/13813455.2021.1874997. Epub 2021 Jan 21.

DOI:10.1080/13813455.2021.1874997
PMID:33476191
Abstract

It is reported that elevated visfatin level is associated with gestational diabetes mellitus (GDM). However, the relationship between visfatin level and GDM remains controversial. The aim of our study was to systematically review available literature linking visfatin to GDM for a comprehensive understanding of the relationship between circulating visfatin level and GDM in human. PubMed, The Cochrane Library and Web of Science were searched for studies published up to July 2020. Standard mean difference with 95% confidence interval was calculated to evaluate the relationship between visfatin level and GDM using the Review Manager 5.3 and Stata 12.0. The evidence indicated that no significant difference was observed in the level of circulating visfatin between the women with GDM and normal glucose tolerance, suggesting circulating visfatin level is not independently related to GDM. Nevertheless, visfatin is involved in the development of GDM in obese women.

摘要

据报道,高水平的内脂素与妊娠期糖尿病(GDM)有关。然而,内脂素水平与 GDM 之间的关系仍存在争议。本研究旨在系统地回顾目前有关内脂素与 GDM 关系的文献,以全面了解人循环内脂素水平与 GDM 之间的关系。我们检索了截至 2020 年 7 月发表的 PubMed、The Cochrane Library 和 Web of Science 上的研究。使用 Review Manager 5.3 和 Stata 12.0 计算标准化均数差及其 95%置信区间,以评估内脂素水平与 GDM 之间的关系。研究结果表明,GDM 组和正常糖耐量组妇女的循环内脂素水平无显著差异,提示循环内脂素水平与 GDM 无独立相关性。然而,内脂素参与了肥胖妇女 GDM 的发生发展。

相似文献

1
Visfatin level and gestational diabetes mellitus: a systematic review and meta-analysis.内脂素水平与妊娠期糖尿病:系统评价和荟萃分析。
Arch Physiol Biochem. 2021 Oct;127(5):468-478. doi: 10.1080/13813455.2021.1874997. Epub 2021 Jan 21.
2
Association between circulating visfatin and gestational diabetes mellitus: a systematic review and meta-analysis.循环内脂素与妊娠期糖尿病的相关性:系统评价和荟萃分析。
Acta Diabetol. 2018 Nov;55(11):1113-1120. doi: 10.1007/s00592-018-1188-x. Epub 2018 Jul 10.
3
Homocysteine level and gestational diabetes mellitus: a systematic review and meta-analysis.同型半胱氨酸水平与妊娠期糖尿病:一项系统评价和荟萃分析。
Gynecol Endocrinol. 2021 Nov;37(11):987-994. doi: 10.1080/09513590.2021.1967314. Epub 2021 Aug 19.
4
Circulating visfatin levels in the second and third trimester of pregnancies with gestational diabetes: a systematic review.妊娠期糖尿病孕妇妊娠中期和晚期循环内脂素水平:一项系统评价
Minerva Ginecol. 2019 Aug;71(4):329-343. doi: 10.23736/S0026-4784.18.04293-4.
5
Relationship of maternal serum resistin and visfatin levels with gestational diabetes mellitus.孕妇血清抵抗素和内脂素水平与妊娠期糖尿病的关系。
Gynecol Endocrinol. 2014 May;30(5):355-8. doi: 10.3109/09513590.2014.887670. Epub 2014 Feb 10.
6
Visfatin in human pregnancy: maternal gestational diabetes vis-à-vis neonatal birthweight.人妊娠中的内脂素:母体妊娠期糖尿病与新生儿出生体重。
J Perinat Med. 2009;37(3):218-31. doi: 10.1515/JPM.2009.053.
7
[Role of visfatin in the pathogenesis of gestational diabetes mellitus and its relationship with insulin resistance].内脂素在妊娠期糖尿病发病机制中的作用及其与胰岛素抵抗的关系
Zhonghua Fu Chan Ke Za Zhi. 2014 Aug;49(8):584-7.
8
Visfatin concentration is decreased in women with gestational diabetes mellitus in the third trimester.孕晚期患有妊娠期糖尿病的女性体内内脂素浓度降低。
J Endocrinol Invest. 2008 Jul;31(7):610-3. doi: 10.1007/BF03345611.
9
Increased visfatin concentrations in women with gestational diabetes mellitus.妊娠期糖尿病女性中内脂素浓度升高。
Clin Sci (Lond). 2006 May;110(5):605-9. doi: 10.1042/CS20050363.
10
Maternal serum visfatin at 11-13 weeks of gestation in gestational diabetes mellitus.妊娠糖尿病孕妇 11-13 孕周血清内脂素水平。
Clin Chem. 2011 Apr;57(4):609-13. doi: 10.1373/clinchem.2010.159806. Epub 2011 Feb 15.

引用本文的文献

1
White adipose tissue in type 2 diabetes and the effect of antidiabetic drugs.2型糖尿病中的白色脂肪组织及抗糖尿病药物的作用
Diabetol Metab Syndr. 2025 Apr 4;17(1):116. doi: 10.1186/s13098-025-01678-9.
2
Relationship of visfatin with obesity and osteoporosis in patients with inflammatory bowel disease: a narrative review.内脏脂肪素与炎症性肠病患者肥胖及骨质疏松症的关系:一篇叙述性综述
Front Immunol. 2025 Mar 18;16:1533955. doi: 10.3389/fimmu.2025.1533955. eCollection 2025.
3
Somatic Changes of Maternal High-Fat Diet on Offspring-Possible Deleterious Effects of Flavonoids?
母体高脂饮食对后代的体细胞变化——类黄酮可能的有害影响?
Nutrients. 2024 Nov 24;16(23):4022. doi: 10.3390/nu16234022.
4
Visfatin exerts an anti-proliferative and pro-apoptotic effect in the human placenta cells†.内脂素对人胎盘细胞具有抗增殖和促凋亡作用† 。
Biol Reprod. 2025 Feb 14;112(2):375-391. doi: 10.1093/biolre/ioae168.
5
Association of circulating visfatin level and metabolic fatty liver disease: An updated meta-analysis and systematic review.循环内脂素水平与代谢性脂肪性肝病的相关性:一项更新的荟萃分析和系统评价。
Medicine (Baltimore). 2024 Sep 13;103(37):e39613. doi: 10.1097/MD.0000000000039613.
6
Expression of visfatin in gingival crevicular fluid and gingival tissues in different periodontal conditions: a cross-sectional study.不同牙周状况龈沟液和牙龈组织中内脂素的表达:一项横断面研究。
BMC Oral Health. 2024 May 2;24(1):514. doi: 10.1186/s12903-024-04299-2.
7
Adipokines in Pregnancy: A Systematic Review of Clinical Data.孕期脂肪因子:临床数据的系统评价
Biomedicines. 2023 May 11;11(5):1419. doi: 10.3390/biomedicines11051419.
8
Differential Association of Selected Adipocytokines, Adiponectin, Leptin, Resistin, Visfatin and Chemerin, with the Pathogenesis and Progression of Type 2 Diabetes Mellitus (T2DM) in the Asir Region of Saudi Arabia: A Case Control Study.沙特阿拉伯阿西尔地区特定脂肪细胞因子(脂联素、瘦素、抵抗素、内脂素和趋化素)与2型糖尿病(T2DM)发病机制及进展的差异关联:一项病例对照研究
J Pers Med. 2022 May 1;12(5):735. doi: 10.3390/jpm12050735.